1.Alternative Name:CD8 alpha & beta;CD_antigen: CD8a; CD8 antigen, alpha polypeptide (p32); CD8; CD8a molecule; CD8A; Leu2 T-lymphocyte antigen; LEU2; MAL; OKT8 T-cell antigen; p32; T cell co-receptor; T8 T-cell antigen; T-cell antigen Leu2; T-cell surface glycoprotein CD8 alpha chain; T-lymphocyte differentiation antigen T8/Leu-2
2.Target:CD8
3.Source:Human CD8A & CD8B Heterodimer was expressed from HEK293 with poly His at the C-terminal,P01732（Ser22-Asp182）&P10966（Leu22-Pro170）
4.Sequence:P01732&P10966
5.Protein structure:P01732&P10966His
6.Molecular Characterization:The protein has a calculated MW of 38kDa.The reducing (R) heterodimer protein migrates as 50-70 kDa due to glycosylation
7.Purity:SDS-PAGE>95%，SEC>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
Note:For research use only .


11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 95%.

12.SPR

Anti-Human CD8A antibody（Cat.No.B22257501）captured on Protein A chip , can bind Recombinant Human CD8A & CD8B Heterodimer/His Protein（Cat.No.B22217504） with a KD constant of 2.39E-08 M, determined in a SPR assay .

13.SPR

Anti-Human CD8A antibody（Cat.No.B22257502）captured on Protein A chip , can bind Recombinant Human CD8A & CD8B Heterodimer/His Protein（Cat.No.B22217504） with a KD constant of 1.76E-08 M, determined in a SPR assay .

14.SPR

Anti-Human CD8B Antibody（Cat.No.B21886703）captured on Protein A chip , can bind Recombinant Human CD8A & CD8B Heterodimer/His Protein（Cat.No.B22217504） with a KD constant of 2.58E-09 M, determined in a SPR assay .